Sumitomo Mitsui Trust Holdings, Inc. Exelixis, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 49,849 shares of EXEL stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,849Holding current value
$2.27 Million% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding EXEL
# of Institutions
642Shares Held
257MCall Options Held
1.67MPut Options Held
733K-
Black Rock Inc. New York, NY33.5MShares$1.53 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.31 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1.03 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$676 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$538 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...